Skip to main content
. 2023 Jun 16;24:410. doi: 10.1186/s13063-023-07425-7

Fig. 1.

Fig. 1

Study design flow chart. The 26-week study will include baseline evaluation (T0) for 2 days, an intervention time of 10 days, and efficacy will be assessed after intervention for 2 days (T1), 4 weeks (T2), 12 weeks (T3) and 24 weeks (T4)